ARCHIVES

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

NCI blocked groups from phase III Iressa studies.

April 30, 2004

Survivors Urge Congress To Include Oral Drug Coverage In Medicare Legislation

October 11, 2002

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

Program Committee Lists 10 Papers At AACR Meeting

July 19, 1985

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

March 5, 1999

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 12, 1990